Inappropriate prescribing of gastric acid suppressants: A systematic literature review and meta‐analysis
British Journal of Clinical Pharmacology · 03.11.2026
DOI: 10.1002/bcp.70883 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 03.11.2026. Verfasst von Dhani Wijaya und 5 weiteren Autor:innen. Beteiligte Einrichtung: Unit of PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Beasiswa Indonesia Bangkit (BIB), Ministry of Religion of the Republic of Indonesia.
Abstract (Originalsprache)
Aim
Inappropriate prescribing of gastric acid suppressants (GASs) may compromise treatment outcomes. This study aimed to examine the prevalence of inappropriate prescribing of GASs in all healthcare settings.
Methods
This PROSPERO‐registered systematic literature review used PubMed and Embase databases to identify original English‐language studies published between 1 January 2000 and 15 December 2025. Studies reporting the number of inappropriate GASs prescribing among patients receiving GASs were included. EndNote, Rayyan and ASReview were used to select studies.
Results
Overall, 141 studies from 44 countries were included. The number of patients in the studies ranged from 36 to 922 436. The pooled prevalence of inappropriate prescribing for all continents was 53% (95% confidence interval [CI]: 49% to 57%), prediction interval 15% to 89%, I 2 = 99.9% and τ 2 = 0.92. Doi plots of the publication bias analysis showed asymmetry in some models (Luis Furuya–Kanamori index = −4.48), but the Copas‐adjusted estimate for the overall dataset was essentially identical to the unadjusted pooled estimate, indicating that although small‐study effects may be present, publication bias is unlikely to affect the overall pooled prevalence. Based on our dataset, we selected several moderators to evaluate. From the selected moderators, we found that the study setting was the factor significantly associated with differences in the pooled prevalence ( P = 0.02).
Conclusion
Across published studies, approximately half of prescribed GASs was classified as inappropriate. This result highlights the global need for healthcare providers to effectively prevent and discontinue the inappropriate prescribing of GASs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Unit of PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands.
- Department of Pharmacy, Faculty of Medicine and Health Sciences, Universitas Islam Negeri Maulana Malik Ibrahim, Malang, Indonesia.
- Department of Clinical Pharmacy, Deventer Teaching Hospital, Deventer, The Netherlands.
ORCID-Profile: Dhani Wijaya, Frank G A Jansman
Förderung
- Beasiswa Indonesia Bangkit (BIB), Ministry of Religion of the Republic of Indonesia
Zitieren
APA
Wijaya, D., Murdani, A. L., Balafas, S., Rollema, C., Jansman, F. G. A., & Taxis, K. (2026). Inappropriate prescribing of gastric acid suppressants: A systematic literature review and meta‐analysis. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70883
Vancouver
Wijaya D, Murdani AL, Balafas S, Rollema C, Jansman FGA, Taxis K. Inappropriate prescribing of gastric acid suppressants: A systematic literature review and meta‐analysis. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70883
BibTeX
@article{Wijaya2026,
author = {Wijaya, Dhani and Murdani, Aly Lamuri and Balafas, Spyros and Rollema, Corine and Jansman, Frank G A and Taxis, Katja},
title = {Inappropriate prescribing of gastric acid suppressants: A systematic literature review and meta‐analysis},
journal = {British Journal of Clinical Pharmacology},
year = {2026},
doi = {10.1002/bcp.70883}
}
EUVIMED